Showing results (31-40 of 58) with videos related to
Sort By:
Pageof 6
Journal of Virology|January 9, 2015
Identification and characterization of the binding site of the respiratory syncytial virus phosphoprotein to RNA-free nucleoproteinMarie Galloux, Gaëlle Gabiane, Julien Sourimant, et al.Science Advances|August 1, 2025
A pan-respiratory virus attachment inhibitor with high potency in human airway models and in vivoGregory Mathez, Paulo Jacob Silva, Vincent Carlen, et al.Plos Pathogens|March 1, 2018
RSV hijacks cellular protein phosphatase 1 to regulate M2-1 phosphorylation and viral transcriptionCharles-Adrien Richard, Vincent Rincheval, Safa Lassoued, et al.Veterinary Research|April 18, 2023
Screening antivirals with a mCherry-expressing recombinant bovine respiratory syncytial virus: a proof of concept using cyclopamineJenna Fix, Delphyne Descamps, Marie Galloux, et al.Journal of Molecular Biology|July 30, 2022
Respiratory Syncytial Virus NS1 Protein Targets the Transactivator Binding Domain of MED25Jiawei Dong, Vincent Basse, Maxime Bierre, et al.International Journal of Molecular Sciences|January 8, 2023
Investigation of the Fuzzy Complex between RSV Nucleoprotein and Phosphoprotein to Optimize an Inhibition Assay by Fluorescence PolarizationSilva Khodjoyan, Deborha Morissette, Fortune Hontonnou, et al.Science Advances|May 1, 2026
In vitro liquid-liquid phase separation induced by respiratory syncytial virus proteins and RNAVincent Basse, Tanushree Agarwal, Tomas Sneideris, et al.Influenza and Other Respiratory Viruses|October 17, 2022
Level of maternal antibodies against respiratory syncytial virus (RSV) nucleoprotein at birth and risk of RSV very severe lower respiratory tract infectionMatthieu Receveur, Michèle Ottmann, Jean-Marc Reynes, et al.Antimicrobial Agents and Chemotherapy|July 15, 2020
Targeting the Respiratory Syncytial Virus N<sup>0</sup>-P Complex with Constrained α-Helical Peptides in Cells and MiceMarie Galloux, Nadège Gsponer, Vanessa Gaillard, et al.International Journal of Molecular Sciences|January 11, 2024
A New Derivative of Retro-2 Displays Antiviral Activity against Respiratory Syncytial VirusAdrien Le Rouzic, Jenna Fix, Robin Vinck, et al.Pageof 6